Richard E. Lowenthal, President and CEO: ARS Pharmaceuticals SPRY Planned sale · Filed 09/02

Trade details

Type: Planned sale notice
Stock: ARS Pharmaceuticals SPRY
Person: Richard E. LowenthalPresident and CEO
Planned sale date: 26/09/02
Filed: 26/09/02

More to sell after $786.4K in 3 months

ARS Pharmaceuticals trades, last 26 weeks

What else happened in ARS Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 08/03~10/02

Richard E. Lowenthal's recent trades

Richard E. LowenthalPresident and CEO
Planned saleARS Pharmaceuticals
Planned sale
ARS Pharmaceuticals
SPRY
$177K
35,000 sh
$177K
Filed 09/11
Traded 09/11
Richard E. LowenthalPresident and CEO
Planned saleARS Pharmaceuticals
Planned sale
ARS Pharmaceuticals
SPRY
$421.1K
75,000 sh
$421.1K
Filed 09/04
Traded 09/04
Richard E. LowenthalPresident and CEO
Planned saleARS Pharmaceuticals
Planned sale
ARS Pharmaceuticals
SPRY
$115.6K
19,805 sh
$115.6K
Filed 09/03
Traded 09/03
Richard E. LowenthalPresident and CEO
Planned saleARS Pharmaceuticals
Planned sale
ARS Pharmaceuticals
SPRY
$148.2K
25,000 sh
$148.2K
Filed 08/20
Traded 08/20
Richard E. LowenthalPresident and CEO
Planned saleARS Pharmaceuticals
Planned sale
ARS Pharmaceuticals
SPRY
$322.3K
50,000 sh
$322.3K
Filed 08/19
Traded 08/19